Comparison of Treatment Outcomes Between Gemcitabine With Nab-Paclitaxel and Modified FOLFIRINOX for First-Line Chemotherapy in Metastatic and Recurrent Pancreatic Cancer: Propensity Score Matching
Conclusions
Gemcitabine with nab-paclitaxel had a higher disease control rate and lower rates of severe anorexia and diarrhea in our propensity-matched population.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Anorexia | Cancer | Cancer & Oncology | Carbohydrates | Chemotherapy | Eating Disorders & Weight Management | Eloxatin | Gastroenterology | Pancreas | Pancreatic Cancer